Instead of using programming code, researchers can simply 'talk' to the Medeloop AI platform. And grant applications? Medeloop can make that easier, too.
Study shows an increased risk of breast cancer recurrence in postmenopausal patients with obesity and HR+ early-stage breast cancer treated with aromatase inhibitors.
